These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma. Brauch H; Weirich G; Hornauer MA; Störkel S; Wöhl T; Brüning T J Natl Cancer Inst; 1999 May; 91(10):854-61. PubMed ID: 10340905 [TBL] [Abstract][Full Text] [Related]
9. The importance of reliable exposure estimates in deciding whether trichloroethylene can cause kidney cancer. Cherrie JW; Kromhout H; Semple S J Cancer Res Clin Oncol; 2001; 127(6):400-4. PubMed ID: 11414201 [No Abstract] [Full Text] [Related]
10. Germline and somatic mutations in von Hippel-Lindau disease gene and its significance in the development of kidney cancer. Shuin T; Kondo K; Ashida S; Okuda H; Yoshida M; Kanno H; Yao M Contrib Nephrol; 1999; 128():1-10. PubMed ID: 10597373 [No Abstract] [Full Text] [Related]
11. The challenge of kidney lesions in von Hippel-Lindau disease. Neumann HP; Riegler P; Huber W; Corradini R; Sessa A; Fontana D; Wetterauer U; Janetschek G Contrib Nephrol; 2001; (136):193-207. PubMed ID: 11688380 [No Abstract] [Full Text] [Related]
12. Pathological excretion patterns of urinary proteins in renal cell cancer patients exposed to trichloroethylene. Brüning T; Mann H; Melzer H; Sundberg AG; Bolt HM Occup Med (Lond); 1999 Jul; 49(5):299-305. PubMed ID: 10628055 [TBL] [Abstract][Full Text] [Related]
13. Renal cell cancer risk and occupational exposure to trichloroethylene: results of a consecutive case-control study in Arnsberg, Germany. Brüning T; Pesch B; Wiesenhütter B; Rabstein S; Lammert M; Baumüller A; Bolt HM Am J Ind Med; 2003 Mar; 43(3):274-85. PubMed ID: 12594774 [TBL] [Abstract][Full Text] [Related]
14. [Current progress in the diagnosis and treatment of renal cell carcinoma]. Tsukamoto T; Takahashi A; Kitamura H Nihon Jinzo Gakkai Shi; 2002 Dec; 44(8):779-85. PubMed ID: 12607966 [No Abstract] [Full Text] [Related]
15. Somatic von Hippel-Lindau disease gene mutation in clear-cell renal carcinomas associated with end-stage renal disease/acquired cystic disease of the kidney. Yoshida M; Yao M; Ishikawa I; Kishida T; Nagashima Y; Kondo K; Nakaigawa N; Hosaka M Genes Chromosomes Cancer; 2002 Dec; 35(4):359-64. PubMed ID: 12378530 [TBL] [Abstract][Full Text] [Related]
16. Renal cell carcinoma development in the rat independent of alterations at the VHL gene locus. Walker C; Ahn YT; Everitt J; Yuan X Mol Carcinog; 1996 Feb; 15(2):154-61. PubMed ID: 8599582 [TBL] [Abstract][Full Text] [Related]
18. Erythropoietin, tumours and the von Hippel-Lindau gene: towards identification of mechanisms and dysfunction of oxygen sensing. Wiesener MS; Eckardt KU Nephrol Dial Transplant; 2002 Mar; 17(3):356-9. PubMed ID: 11865075 [No Abstract] [Full Text] [Related]
19. Molecular detection of von Hippel-Lindau gene mutations in urine and lymph node samples in patients with renal cell carcinoma: potential biomarkers for early diagnosis and postoperative metastatic status. Ashida S; Furihata M; Tanimura M; Sugita O; Yamashita M; Miura T; Moriyama M; Shuin T J Urol; 2003 Jun; 169(6):2089-93. PubMed ID: 12771725 [TBL] [Abstract][Full Text] [Related]
20. [VHL, angiogenesis and renal carcinoma: the puzzle is complete]. Richard S Ann Pathol; 2000 Mar; 20(2):107-9. PubMed ID: 10740003 [No Abstract] [Full Text] [Related] [Next] [New Search]